These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 14533450)
1. UFT and oral leucovorin as radiation sensitizers in rectal and other gastrointestinal malignancies. Saad ED; Hoff PM Cancer Invest; 2003; 21(4):624-9. PubMed ID: 14533450 [TBL] [Abstract][Full Text] [Related]
2. Preoperative combined oral UFT plus leucovorin and radiation therapy for rectal cancer. Diaz-Canton E; Pazdur R Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):58-60. PubMed ID: 9348571 [TBL] [Abstract][Full Text] [Related]
3. The role of UFT in combined-modality therapy. Blanke CD; Teng M; Choy H Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):47-54. PubMed ID: 10550826 [TBL] [Abstract][Full Text] [Related]
5. Phase I study of oral uracil and Tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer. Schiebe ME; Reese T; Wenz F; Schmidberger H; Engenhart-Cabillic R; Dunst J; Hess CF; Hoffmann W Anticancer Drugs; 2002 Nov; 13(10):1005-9. PubMed ID: 12439334 [TBL] [Abstract][Full Text] [Related]
6. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer. Hoff PM; Janjan N; Saad ED; Skibber J; Crane C; Lassere Y; Cleary KR; Benner S; Randolph J; Abbruzzese JL; Pazdur R J Clin Oncol; 2000 Oct; 18(20):3529-34. PubMed ID: 11032595 [TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin. de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446 [TBL] [Abstract][Full Text] [Related]
8. A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancer. Hoff PM; Saad ED; Janjan N; Skibber J; Pazdur R Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):56-8. PubMed ID: 11098495 [TBL] [Abstract][Full Text] [Related]
9. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer. Hoff PM; Pazdur R; Benner SE; Canetta R Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235 [TBL] [Abstract][Full Text] [Related]
10. UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: a comprehensive review. Minsky BD Int J Cancer; 2001 Feb; 96(1):1-10. PubMed ID: 11241325 [TBL] [Abstract][Full Text] [Related]
11. UFT (tegafur-uracil) in rectal cancer. Casado E; Pfeiffer P; Feliu J; González-Barón M; Vestermark L; Jensen HA Ann Oncol; 2008 Aug; 19(8):1371-1378. PubMed ID: 18381370 [TBL] [Abstract][Full Text] [Related]
12. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer. Kundel Y; Brenner B; Symon Z; Oberman B; Sadezki S; Koller M; Catane R; Pfeffer R Anticancer Res; 2007; 27(4C):2877-80. PubMed ID: 17695464 [TBL] [Abstract][Full Text] [Related]
13. Current and future directions in adjuvant combined-modality therapy of rectal cancer. Minsky BD Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):61-8. PubMed ID: 9348572 [TBL] [Abstract][Full Text] [Related]
14. Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer. Byström P; Frödin JE; Berglund A; Wilking N; Glimelius B Radiother Oncol; 2004 Feb; 70(2):171-5. PubMed ID: 15028404 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study. Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434 [TBL] [Abstract][Full Text] [Related]
16. Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer. Tedesco KL; Berlin J; Blanke CD; Teng M; Choy H; Roberts J; Beauchamp RD; Leach S; Wyman K; Tarpley J; Shyr Y; Caillouette C; Chakravarthy B Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1364-70. PubMed ID: 15817338 [TBL] [Abstract][Full Text] [Related]
18. Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients. Damle B; Ravandi F; Kaul S; Sonnichsen D; Ferreira I; Brooks D; Stewart D; Alberts D; Pazdur R Clin Cancer Res; 2001 Mar; 7(3):517-23. PubMed ID: 11297242 [TBL] [Abstract][Full Text] [Related]
19. The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potential. Hoff PM Invest New Drugs; 2000 Nov; 18(4):331-42. PubMed ID: 11081569 [TBL] [Abstract][Full Text] [Related]
20. [Complete disappearance of pulmonary metastases in a case of rectal cancer treated with oral tegafur-uracil (UFT) and leucovorin (LV)]. Takada A; Kawahara M; Kobayashi H; Takino Y; Kodama T; Sugishita T; Ohno Y; Oka T; Tsukamoto F Gan To Kagaku Ryoho; 2012 Jun; 39(6):997-9. PubMed ID: 22705701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]